Our main finding in this study is that elevated CTRP9 level was not only an independently protective factor against onset of ischemic stroke in non-hyperlipidemic subjects, but also consistently was indicative of lower all-cause and cardiovascular mortality in general patients of first-ever ischemic stroke for at least 1 year. The gene discussed is C1QTNF9; the disease is ischemic stroke.